Company intelligence / Profile preview

Coastal

Lexington, Kentucky, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Coastal Biotech is a CLIA-accredited molecular diagnostics laboratory providing PCR-based testing services for infectious disease and antimicrobial-resistance related clinical use. The company markets a commercial test menu spanning COVID-19, respiratory, gastrointestinal, urinary tract, sexually transmitted, and wound infections, and emphasizes same-day reporting and clinician-friendly therapeutic guidance. Its business appears to center on laboratory-developed or laboratory-run diagnostic services rather than a therapeutic drug pipeline. Coastal Biotech serves physicians, home health, long-term care, and hospital customers in the United States.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Coastal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coastal.

Explore the full profile